Streptococcus salivarius is found mainly in the mouth, especially on the tongue surface and oral mucosa, and in the upper respiratory tract, including the throat. It is one of the first bacteria to colonise the mouth after birth. Smaller numbers pass through or reside in the gastrointestinal tract, where it contributes to microbial balance.

Streptococcus salivarius is generally well tolerated, and side effects from probiotic strains are uncommon and usually mild, such as temporary digestive discomfort. Rare opportunistic infections have been reported, mainly in severely ill or immunocompromised people. Anyone with a serious medical condition, weakened immunity or heart valve problems should consult a healthcare professional before use.

Streptococcus salivarius is a pioneer and dominant commensal of the oral microbiome, especially on the tongue. Certain strains produce bacteriocins (often called salivaricins) and antimicrobial peptides that compete with undesirable microbes. Research suggests this supports oral and throat microbiota balance, which is why selected strains are used in lozenges, chewables and oral care products.

Streptococcus salivarius benefits include support for oral and throat microbiota balance, digestive comfort, immune system modulation and healthy mucosal barrier function. It is suitable for paediatric, adult and general wellness formulations. SwissMedicare Probiotics supplies freeze-dried Streptococcus salivarius powder at 1–50 billion CFU/g for supplements, oral care products and functional foods.

Streptococcus salivarius is not typically obtained from foods; it lives naturally in the human mouth and throat. Unlike its close relative Streptococcus thermophilus, which is used in yogurt, it is not a standard dairy starter culture. Targeted intake usually comes from probiotic lozenges, chewables, mouth sprays, supplements or fortified functional foods made with characterised strains.

Streptococcus salivarius works by colonising the oral cavity and gastrointestinal tract and competing with undesirable microbes for space and nutrients. Selected strains produce bacteriocins and antimicrobial peptides, tolerate acidic and bile conditions, and help maintain microbial balance in oral and gut ecosystems. Research suggests this also supports mucosal barrier function and immune modulation.

There is no universal recommended dosage of Streptococcus salivarius; dose depends on the strain, product format, intended use and local regulations. SwissMedicare Probiotics offers potency ranges of 1 billion to 50 billion CFU/g, with custom CFU strengths for formulators. Finished-product dosing should be set by the brand's formulation and regulatory team or a healthcare professional.

Yes, Streptococcus salivarius can be combined with other probiotic strains in multi-strain formulations, and it is compatible with prebiotics for synbiotic products. It is often paired with oral-health or digestive strains in lozenges, chewables, capsules and powders. Compatibility and stability should be tested per formula. SwissMedicare Probiotics supports single- and multi-strain custom formulation.

Yes, Streptococcus salivarius is considered suitable for probiotic formulations when well-characterised, safety-assessed strains are used, and it has a human-origin commensal profile. SwissMedicare Probiotics produces it under GMP and ISO-certified conditions, compliant with US FDA dietary supplement regulations and aligned with EU EFSA frameworks, with COA, TDS, MSDS and stability documentation.